APOE and hyperlipidemia: In a mouse model of hyperlipidemia and hyperglycemia (apolipoprotein E/GPx1 (ApoE(−/−)GPx1(−/−))-double knockout (dKO) mice), ebselen significantly reduces NOX2 and oxidative stress ameliorating fibrosis and inflammation in the kidney [119].